In March 2023, the IVDR was amended as regards to transitional provisions for certain in vitro diagnostic (IVD) medical devices on Article 110(4) with the removal of the sell-off period to prevent unnecessary disposal of safe in vitro diagnostic medical devices that are still in the supply chain.
By 26 May 2022 all new IVDs placed on the market and Class A non-sterile devices had to comply with the IVDR.